Status epilepticus (SE) is a neurological emergency that, by definition, can cause neuronal damage and is associated with acute and chronic complications. The acute exacerbation of epileptic activity in status epilepticus (SE) is notably difficult to treat pharmacologically, resulting in high mortality rates of up to 10-20% [1,2]. SE is common in patients with refractory epilepsy, with prevalences ranging from 15% to 35%, and population-based studies reporting prevalences between 15 to and 36 per 100000 adults per year [3,4].
Seguir leyendo →
9
FEB
FEB
0
